Celecoxib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Celecoxib
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Celecoxib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

92 API Suppliers, 31 USDMF, 36 CEP/COS, 10 JDMF, 27 EU WC, 60 KDMF, 28 NDC API, 50 Listed Suppliers, $ API Reference Price

92 API Suppliers
31 USDMF
36 CEP/COS
10 JDMF
27 EU WC
60 KDMF
28 NDC API
50 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

80 Drugs in Development

80 Drugs in Development

INTERMEDIATES

27 Intermediate Suppliers

27 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

356 FDF Dossiers, 100 FDA Orange Book, 127 Europe, 32 Canada, 22 Australia, 15 South Africa, 60 Listed Dossiers

356 FDF Dossiers
100 FDA Orange Book
127 Europe
32 Canada
22 Australia
15 South Africa
60 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 100MG, CAPSULE;ORAL - 200MG, CAPSULE;ORAL - 400MG, CAPSULE;ORAL - 50MG, TABLET;ORAL - EQ 10MG BASE;200MG, TABLET;ORAL - EQ 2.5MG BASE;200MG, TABLET;ORAL - EQ 5MG BASE;200MG

CAPSULE;ORAL - 100MG
CAPSULE;ORAL - 200MG
CAPSULE;ORAL - 400MG
CAPSULE;ORAL - 50MG
TABLET;ORAL - EQ 10MG BASE;200MG
TABLET;ORAL - EQ 2.5MG BASE;200MG
TABLET;ORAL - EQ 5MG BASE;200MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 15 SPI Pharma, 8 DKSH, 6 Faran Shimi Pharmaceutical, 9 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Pramukh Pharmachem, 4 ACG Worldwide, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 3 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 16 Kerry, 3 Lonza Capsugel, 11 Microlex e.U, 1 NEWEDGE Overseas, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 6 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 5 Sigachi Industries, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Fillers, Diluents & Binders, 31 Disintegrants & Superdisintegrants, 26 Direct Compression, 20 Granulation, 19 Lubricants & Glidants, 15 Chewable & Orodispersible Aids, 13 Taste Masking, 13 Solubilizers, 12 Thickeners and Stabilizers, 10 Coating Systems & Additives, 10 Co-Processed Excipients, 8 Parenteral, 8 Empty Capsules, 5 Film Formers & Plasticizers, 4 Topical, 4 Emulsifying Agents, 4 Controlled & Modified Release, 3 Coloring Agents, 2 API Stability Enhancers, 1 Rheology Modifiers, 1 Surfactant & Foaming Agents

59 Fillers, Diluents & Binders
31 Disintegrants & Superdisintegrants
26 Direct Compression
20 Granulation
19 Lubricants & Glidants
15 Chewable & Orodispersible Aids
13 Taste Masking
13 Solubilizers
12 Thickeners and Stabilizers
10 Coating Systems & Additives
10 Co-Processed Excipients
8 Parenteral
8 Empty Capsules
5 Film Formers & Plasticizers
4 Topical
4 Emulsifying Agents
4 Controlled & Modified Release
3 Coloring Agents
2 API Stability Enhancers
1 Rheology Modifiers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

81 NEWS #PharmaBuzz

81 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 95 Finished Drug Prices, 15 Annual Reports

3 US Medicaid Prescriptions
95 Finished Drug Prices
15 Annual Reports

MARKET PLACE

15 APIs, 6 FDF Dossiers

15 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

28 US Patents, 1 US Exclusivities, 6 Health Canada Patents

28 US Patents
1 US Exclusivities
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 21 Others

3 EDQM
3 USP
21 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 57 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Pfizer Canada Inc.

filter Patent Reset all filters

6 All

01 32177576

02 32267186

filter Product Reset all filters

6 All

01 6Celecoxib

filter Dosage Reset all filters

6 All

01 6Capsule

filter Exp Date Reset all filters

6 All

01 32014-11-14

02 32017-10-14

Product Main Page

01

Pfizer Canada Inc.

Celecoxib

The Generic Rx Session

Not Confirmed

Pfizer Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-10-14

Date Granted : 2002-05-14

Brand Name : CELEBREX

Patent Number : 2267186

Filing Date : 1997-10-14

Strength per Unit : 400mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-10-14

Date Granted : 2002-05-14

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada Inc.

Celecoxib

The Generic Rx Session

Not Confirmed

Pfizer Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-11-14

Date Granted : 1999-10-26

Brand Name : CELEBREX

Patent Number : 2177576

Filing Date : 1994-11-14

Strength per Unit : 400mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-11-14

Date Granted : 1999-10-26

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada Inc.

Celecoxib

The Generic Rx Session

Not Confirmed

Pfizer Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-10-14

Date Granted : 2002-05-14

Brand Name : CELEBREX

Patent Number : 2267186

Filing Date : 1997-10-14

Strength per Unit : 100mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-10-14

Date Granted : 2002-05-14

Portfolio PDF

Product Web Link

Digital Content

04

Pfizer Canada Inc.

Celecoxib

The Generic Rx Session

Not Confirmed

Pfizer Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-11-14

Date Granted : 1999-10-26

Brand Name : CELEBREX

Patent Number : 2177576

Filing Date : 1994-11-14

Strength per Unit : 100mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-11-14

Date Granted : 1999-10-26

Portfolio PDF

Product Web Link

Digital Content

05

Pfizer Canada Inc.

Celecoxib

The Generic Rx Session

Not Confirmed

Pfizer Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-10-14

Date Granted : 2002-05-14

Brand Name : CELEBREX

Patent Number : 2267186

Filing Date : 1997-10-14

Strength per Unit : 200mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-10-14

Date Granted : 2002-05-14

Portfolio PDF

Product Web Link

Digital Content

06

Pfizer Canada Inc.

Celecoxib

The Generic Rx Session

Not Confirmed

Pfizer Canada Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-11-14

Date Granted : 1999-10-26

Brand Name : CELEBREX

Patent Number : 2177576

Filing Date : 1994-11-14

Strength per Unit : 200mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-11-14

Date Granted : 1999-10-26

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!